Related Experiment Videos
Aleutian mink disease: puzzles and paradigms
1Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, Hamilton, Montana 59840.
Summary
Aleutian mink disease (AD) is a persistent parvovirus infection in mink. Chronic interleukin-6 production, linked to ADV infection, may drive the immune disorder characteristic of this disease.
Area of Science:
- Veterinary Virology
- Immunology
- Pathology
Background:
- Aleutian mink disease (AD) is a persistent parvovirus infection in mink caused by the Aleutian mink disease parvovirus (ADV).
- The classical form of AD involves high antibody titers, hypergammaglobulinemia, plasmacytosis, immune complex disease, and progressive renal pathology.
- ADV infection in newborn kits causes fatal interstitial pneumonitis, which can be altered by antiviral antibody treatment.
Purpose of the Study:
- To investigate the role of interleukin-6 (IL-6) in the pathogenesis of Aleutian mink disease.
- To understand the cellular mechanisms of ADV replication and immune response in mink and cell lines.
Main Methods:
- Analysis of ADV infection in adult and newborn mink, including clinical signs, antibody titers, and renal pathology.
- In vitro studies using mink primary macrophages and the U937 human macrophage cell line to assess ADV replication and cytokine production.
- Measurement of interleukin-6 levels in lymph node culture supernatants from infected mink.
Main Results:
- ADV infection leads to immune complex deposition in lymphoid organs, with limited viral replication in macrophages and follicular dendritic cells.
- ADV infection of macrophages is antibody-dependent and induces the production of interleukin-6.
- Elevated interleukin-6 levels were observed in lymph node cultures from infected mink.
Conclusions:
- Chronic interleukin-6 production, stimulated by ADV infection, may contribute to the development of the immune disorder in Aleutian mink disease.
- Understanding the interplay between ADV, host immune response, and cytokine production is crucial for managing this disease.